Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours

被引:0
|
作者
Mira M. Shenouda
Amy Gillgrass
Tina Nham
Richard Hogg
Amanda J. Lee
Marianne V. Chew
Mahsa Shafaei
Craig Aarts
Dean A. Lee
John Hassell
Anita Bane
Sukhbinder Dhesy-Thind
Ali A. Ashkar
机构
[1] McMaster University,Department of Pathology and Molecular Medicine, McMaster Immunology Research Centre
[2] Nationwide Children’s Hospital,Cellular Therapy and Cancer Immunology Program, Department of Hematology/Oncology and BMT
[3] The Ohio State University Comprehensive Cancer Center,Department of Oncology
[4] McMaster University,undefined
来源
关键词
Immunotherapy; PDX; NK cell expansion; NK cell therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteers
    Kim, Eun-Kyung
    Ahn, Yong-Oon
    Kim, Saerom
    Kim, Tae Min
    Keam, Bhumsuk
    Heo, Dae Seog
    CYTOTHERAPY, 2013, 15 (02) : 231 - 241
  • [22] Ex vivo activation and expansion of natural killer cells from advanced cancer patients with feeder cells from healthy volunteers
    Kim, Eunkyung
    Ahn, Yong-Oon
    Kim, Saerom
    Kim, Tae Min
    Keam, Bhumsuk
    Heo, Dae Seog
    CANCER RESEARCH, 2012, 72
  • [23] Cytotoxic Effects on Breast Cancer Cell Lines of Chalcones Derived from a Natural Precursor and Their Molecular Docking Analysis
    Bustos, Luis
    Echiburu-Chau, Carlos
    Castro-Alvarez, Alejandro
    Bradshaw, Ben
    Simirgiotis, Mario J.
    Mellado, Marco
    Parra, Claudio
    Cuellar, Mauricio
    MOLECULES, 2022, 27 (14):
  • [24] Dual CAR-Targeted Natural Killer Cell Lines Demonstrate Potent Cytotoxic Properties Towards Breast Cancer Cells
    Kravchenko, Yulia Evgenyevna
    Frolova, Elena Ivanovna
    Chumakov, Stepan Petrovich
    INTERNATIONAL JOURNAL OF APPLIED EXERCISE PHYSIOLOGY, 2020, 9 (12): : 13 - 19
  • [25] Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cells
    Tina Nham
    Sophie M. Poznanski
    Isabella Y. Fan
    Mira M. Shenouda
    Marianne V. Chew
    Amanda J. Lee
    Fatemeh Vahedi
    Yalda Karimi
    Martin Butcher
    Dean A. Lee
    Hal Hirte
    Ali A. Ashkar
    Cancer Immunology, Immunotherapy, 2018, 67 : 575 - 587
  • [26] Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cells
    Nham, Tina
    Poznanski, Sophie M.
    Fan, Isabella Y.
    Shenouda, Mira M.
    Chew, Marianne V.
    Lee, Amanda J.
    Vahedi, Fatemeh
    Karimi, Yalda
    Butcher, Martin
    Lee, Dean A.
    Hirte, Hal
    Ashkar, Ali A.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (04) : 575 - 587
  • [27] Ex vivo expanded Natural Killer cells and INTASYL self-delivering RNAi targeting TIGIT as novel immunotherapeutic strategy in breast cancer
    Roersma, Sabine
    Maxwell, Melissa
    Cardia, James
    Bos, Gerard M. J.
    Dispersyn, Gerrit
    Fricker, Simon P.
    Germeraad, Wilfred T. V.
    Wieten, Lotte
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 396 - 396
  • [28] Correction to: In Vivo Modeling of Human Breast Cancer Using Cell Line and Patient-Derived Xenografts
    Eric P. Souto
    Lacey E. Dobrolecki
    Hugo Villanueva
    Andrew G. Sikora
    Michael T. Lewis
    Journal of Mammary Gland Biology and Neoplasia, 2022, 27 : 231 - 231
  • [29] POTENT ANTITUMOR EFFICACY OF EX VIVO EXPANDED AND CRYOPRESERVED HUMAN NATURAL KILLER CELLS AGAINST ORTHOTOPIC PANCREATIC CANCER
    Park, G.
    Yang, B.
    Kim, E.
    Kim, H.
    Kim, Y.
    Cho, S.
    Hwang, Y.
    Min, B.
    CYTOTHERAPY, 2019, 21 (05) : S35 - S35
  • [30] Exosomes derived from natural killer cells: transforming immunotherapy for aggressive breast cancer
    Altamimi, Abdulmalik Saleh Alfawaz
    Babu, M. Arockia
    Afzal, Muhammad
    Bishoyi, Ashok Kumar
    Roopashree, R.
    Saini, Suman
    Sharma, R. S. K.
    Pathak, Piyus Kumar
    Chauhan, Ashish Singh
    Goyal, Kavita
    Ali, Haider
    Khan, Nawaid Hussain
    Balaraman, Ashok Kumar
    MEDICAL ONCOLOGY, 2025, 42 (04)